1. Home
  2. ORKT vs INTS Comparison

ORKT vs INTS Comparison

Compare ORKT & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORKT
  • INTS
  • Stock Information
  • Founded
  • ORKT 2003
  • INTS 2012
  • Country
  • ORKT Singapore
  • INTS United States
  • Employees
  • ORKT N/A
  • INTS N/A
  • Industry
  • ORKT
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORKT
  • INTS Health Care
  • Exchange
  • ORKT NYSE
  • INTS Nasdaq
  • Market Cap
  • ORKT 34.7M
  • INTS 33.4M
  • IPO Year
  • ORKT 2024
  • INTS 2023
  • Fundamental
  • Price
  • ORKT $1.49
  • INTS $2.27
  • Analyst Decision
  • ORKT Strong Buy
  • INTS Strong Buy
  • Analyst Count
  • ORKT 1
  • INTS 3
  • Target Price
  • ORKT $5.00
  • INTS $8.50
  • AVG Volume (30 Days)
  • ORKT 8.4M
  • INTS 40.6K
  • Earning Date
  • ORKT 10-16-2024
  • INTS 03-13-2025
  • Dividend Yield
  • ORKT N/A
  • INTS N/A
  • EPS Growth
  • ORKT N/A
  • INTS N/A
  • EPS
  • ORKT N/A
  • INTS N/A
  • Revenue
  • ORKT $3,904,592.00
  • INTS N/A
  • Revenue This Year
  • ORKT N/A
  • INTS N/A
  • Revenue Next Year
  • ORKT N/A
  • INTS N/A
  • P/E Ratio
  • ORKT N/A
  • INTS N/A
  • Revenue Growth
  • ORKT N/A
  • INTS N/A
  • 52 Week Low
  • ORKT $0.62
  • INTS $1.50
  • 52 Week High
  • ORKT $8.00
  • INTS $5.94
  • Technical
  • Relative Strength Index (RSI)
  • ORKT N/A
  • INTS 47.38
  • Support Level
  • ORKT N/A
  • INTS $2.12
  • Resistance Level
  • ORKT N/A
  • INTS $2.37
  • Average True Range (ATR)
  • ORKT 0.00
  • INTS 0.32
  • MACD
  • ORKT 0.00
  • INTS -0.02
  • Stochastic Oscillator
  • ORKT 0.00
  • INTS 21.19

About ORKT ORANGEKLOUD TECHNOLOGY INC

Orangekloud Technology Inc is a company that operates through its subsidiaries provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominately in Singapore. It derives revenue from platform subscriptions, license and products and professional services.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with major unmet medical need.

Share on Social Networks: